Machine learning could help predict adherence to HIV treatment in adolescents
Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...
Healio7h
Tecovirimat fails to reduce clade II mpox lesions, pain, viral clearance
Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...
Physician's Weekly13h
Lesion Time and High-Risk Features in Keratinocyte Skin Cancer
The following is a summary of “St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time ...
Science Daily3d
Injectable Therapy is 'magic' for those who can't take HIV pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
MIT Technology Review3d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
ACTG Presents Data from Mpox Study STOMP at CROI
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...